Clinical Trial

Clinical Performance of Novel Coconut Based Restorative Material.

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated June 10, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
A triple-blind, parallel group, randomized trial with an allocation ratio of 1:1. Participants randomly allocated into two groups A and B. In group A, nano-reinforced glass ionomer restoration will be utilized while in group B, glass ionomer restoration without nanoparticles was used. Parameters of clinical performance measured will be: A. Surface structure B. Anatomical shape C. marginal adhesion. Clinical performance of Restorations will be assessed with4-level Ryge's scale at baseline, after 1, 3 and 6 months. The numerical Ryge's scale will be used for comparison of quality of restoration in subsequent control clinical examinations and tracking its changes over time. Parameters will be evaluated on standardized scale 0-3. Restorations that will be rated 0 (very good - ideal condition) and 1 (satisfying - requiring minor corrections) will be considered clinically acceptable. Restorations with rating 2 (need for deferred replacement of the restoration) or 3 (unacceptable - restoration needs to be replaced immediately) will be considered clinically unacceptable.
Trial Details
NCT Number NCT07640074
Lead Sponsor Pakistan Institute of Medical Sciences
Conditions Carious Lesion, Restoration
Enrollment 60 participants
Start Date 2026-06-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-10